Significant Accounting Policies (Details) - USD ($) shares in Thousands, $ in Thousands |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
Sep. 30, 2020 |
|
Accounting Policies [Abstract] | ||||
Foreign currency transaction | $ 181 | $ 230 | ||
Net income | $ 176 | |||
Research and development expenses | $ 28 | $ 327 | ||
Transaction price | 5,000 | |||
Reimbursement cost | $ 1,000 | |||
Option exercise | $ 3,000 | |||
Income tax percentage | 50.00% | |||
Warrants exercisable (in Shares) | 4,008,007 | 3,536,495 | 2,299,684 |
X | ||||||||||
- Definition Option exercise No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized loss recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of other research and development expense. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|